Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

Kayla E. Hanson et al.

Are COVID-19vaccines associated with Guillain-Barré syndrome (GBS)?

In this cohort study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines, the unadjusted incidence rate of confirmed GBS in the 1 to 21 days after receiving the Ad.26.COV2.S (Janssen) vaccine was 32.4 per 100 000 person-years, which was significantly higher than the background rate of GBS. The unadjusted incidence rate of confirmed GBS in the 1 to 21 days after mRNA vaccines was 1.3 per 100 000 person-years, which did not differ from the background rate.

These findings suggest an increased risk of GBS after Ad.26.COV2.S vaccination.

Latest articles

The Weston A. Price Foundation Many people believe that diet has little...
Suzanne Anton (BC’s Attorney General 2013-2017) “COVID is over” are welcome words...
Rebecca A. Clay Can nutrition affect your mental health? A growing research...
Laura Lachance and Drew Ramsey Improved, innovative strategies are needed for the...
Joseph Firth et al. … In recent years, the relationships bet­ween nutrition...
Jaydee Hanson & Julia Ranney It goes by many names: cultured, cell-based,...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!